共 50 条
- [1] Factors driving co-occurrence of Schistosoma mansoni and S. haematobium at the micro-geographical level [J]. Archives of Public Health, 73 (Suppl 1):
- [2] Micro-Geographical Heterogeneity in Schistosoma mansoni and S. haematobium Infection and Morbidity in a Co-Endemic Community in Northern Senegal [J]. PLOS NEGLECTED TROPICAL DISEASES, 2013, 7 (12):
- [3] DRUGS FOR TREATING SCHISTOSOMA HAEMATOBIUM AND S. MANSONI INFECTIONS [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2009, 81 (05): : 180 - 181
- [4] Why does oxamniquine kill Schistosoma mansoni and not S. haematobium and S. japonicum? [J]. INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE, 2020, 13 : 8 - 15
- [6] Modelling age-heterogeneous Schistosoma haematobium and S. mansoni survey data via alignment factors [J]. Parasites & Vectors, 4
- [7] Micro-geographical variation in exposure to Schistosoma mansoni and malaria, and exacerbation of splenomegaly in Kenyan school-aged children [J]. BMC Infectious Diseases, 4
- [8] Cholinergic components of nervous system of Schistosoma mansoni and S. haematobium (Digenea: Schistosomatidae) [J]. Parasitology Research, 2016, 115 : 3127 - 3137
- [9] Efficacy and Safety of Praziquantel in Preschool-Aged Children in an Area Co-Endemic for Schistosoma mansoni and S. haematobium [J]. PLOS NEGLECTED TROPICAL DISEASES, 2012, 6 (12):
- [10] Identification of G protein-coupled receptors in Schistosoma haematobium and S. mansoni by comparative genomics [J]. Parasites & Vectors, 7